Susquehanna International Group
DERM icon

Susquehanna International Group’s Journey Medical DERM Stock Holding History

Susquehanna International Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
20,001
+7,280
+57% +$41.6K ﹤0.01% 12251
2026
Q1 		$59.7K Buy
12,721
+472
+4% +$3.66K ﹤0.01% 12584
2025
Q4 		$94.4K Buy
+12,249
New +$96K ﹤0.01% 11486
2025
Q3 		– Sell
-15,388
Closed -$110K – 12651
2025
Q2 		$110K Sell
15,388
-41,951
-73% -$290K ﹤0.01% 11728
2025
Q1 		$338K Buy
57,339
+38,617
+206% +$190K ﹤0.01% 9792
2024
Q4 		$73.2K Buy
+18,722
New +$102K ﹤0.01% 11515
2022
Q4 		– Sell
-22,094
Closed -$54K – 12638
2022
Q3 		$54K Buy
+22,094
New +$75.3K ﹤0.01% 12146

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Susquehanna International Group's DERM Position: Q2 2026 in Review

Susquehanna International Group increased its Journey Medical (DERM) stake by 57% in Q2 2026, buying an estimated $41.6K and bringing the position to 20,001 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #12251.

Susquehanna International Group first reported a position in DERM in Q3 2022 and has held it in 7 quarters since. The position peaked at $338K in Q1 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Susquehanna International Group held 20,001 shares of Journey Medical worth $142K as of Q2 2026.
  • Susquehanna International Group bought 7,280 Journey Medical shares in Q2 2026, an estimated $41.6K.
  • Journey Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12251 holding.
  • Susquehanna International Group first reported a position in Journey Medical in Q3 2022 and has held it in 7 quarters since.
  • Susquehanna International Group's Journey Medical position peaked at $338K in Q1 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.